Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
---|
10/26/2000 | WO2000062620A2 Transformed cells useful for the control of pests |
10/26/2000 | WO2000062615A1 Neuropeptides and their use for pest control |
10/26/2000 | WO2000031120A3 Hexapeptide with the stabilized disulfide bond and derivatives thereof regulating metabolism, proliferation, differentiation and apoptosis |
10/26/2000 | WO2000020112A3 Chemical constructs and their uses |
10/26/2000 | CA2370301A1 Osteopontin-derived chemotactic and inhibitory agents and uses therefor |
10/26/2000 | CA2370259A1 Pyrrolidincarbonylamino cyclic disulfides |
10/26/2000 | CA2367938A1 Peptides and the use thereof to control pests |
10/26/2000 | CA2365949A1 Adhesion modulatory peptides and methods for use |
10/26/2000 | CA2365220A1 Transformed cells useful for the control of pests |
10/25/2000 | EP1046650A1 PEPTIDES, METHOD FOR ASSAYING HUMAN PEPSINOGEN II or HUMAN PEPSIN II, AND ASSAYING KIT |
10/25/2000 | EP1046421A2 Methods and reagents for very large scale immobilized polymer synthesis |
10/25/2000 | EP1045858A1 Anti-cryptococcal peptides |
10/25/2000 | EP0736039B1 Compounds with growth hormone releasing properties |
10/25/2000 | CN1270960A Process for preparing growth hormone cinogenic agent |
10/25/2000 | CN1057773C N-protection aspartic sweet piptide preparation method |
10/25/2000 | CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders |
10/24/2000 | US6136956 Fibrous assembly of peptide lipid and method for the preparation thereof |
10/24/2000 | US6136834 Tetrazole compounds and pharmaceutical agents containing such derivative |
10/24/2000 | US6136800 Steroids |
10/24/2000 | US6136798 Compounds inhibiting the association of the PDGF receptor and phosphatidylinositol 3-kinase and their use |
10/24/2000 | US6136788 Pharmaceutical preparation for the therapy of immune deficiency conditions |
10/24/2000 | US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors |
10/24/2000 | US6136269 Combinatorial kit for polymer synthesis |
10/19/2000 | WO2000061813A1 A second mammalian tankyrase |
10/19/2000 | WO2000061789A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
10/19/2000 | WO2000061631A1 Modified pentapeptide antagonists of the atrial natriuretic peptide clearance receptor |
10/19/2000 | WO2000061609A2 Prodrugs of thrombin inhibitors |
10/19/2000 | WO2000061608A2 Low-molecular inhibitors of complement proteases |
10/19/2000 | WO2000061577A1 Prodrugs of thrombin inhibitors |
10/19/2000 | WO2000061574A2 Method for producing thiophenyl-amidines |
10/19/2000 | WO2000061542A1 Caspase inhibitors and the use thereof |
10/19/2000 | WO2000061541A2 Pharmaceutical compounds |
10/19/2000 | WO2000061195A1 Benzodiazepine derivatives for imaging thrombi |
10/19/2000 | CA2372171A1 Benzodiazepine derivatives for imaging thrombi |
10/19/2000 | CA2370425A1 Pharmaceutical compounds |
10/19/2000 | CA2370267A1 Prodrugs of thrombin inhibitors |
10/19/2000 | CA2369619A1 Caspase inhibitors and the use thereof |
10/19/2000 | CA2369378A1 Low-molecular inhibitors of complement proteases |
10/19/2000 | CA2369267A1 Method for producing amidines |
10/19/2000 | CA2368830A1 Prodrugs of thrombin inhibitors |
10/19/2000 | CA2366671A1 Methods and reagents for determining enzyme substrate specificity, and uses related thereto |
10/19/2000 | CA2360318A1 A second mammalian tankyrase |
10/18/2000 | EP1044215A1 Anti-inflammatory phenylalanine derivatives |
10/18/2000 | CN1057519C Production of beta-hydroxyalkylamides |
10/17/2000 | US6133463 For use in cosmetic and dermatological compositions for treating or caring for the skin |
10/17/2000 | US6133418 Synthetic peptide inhibitors of HIV transmission |
10/17/2000 | US6133284 Excellent bactericidal properties and oral absorption; infections from gramnegative and -positive bacteria; intestinal absorption, metabolic stability; side effect reduction; nonphototoxicity and noncytotoxicity |
10/17/2000 | US6133256 Selective factor Xa inhibitors |
10/17/2000 | US6132697 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
10/17/2000 | CA2177357C Pna-dna-pna chimeric macromolecules |
10/12/2000 | WO2000059931A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use |
10/12/2000 | WO2000059929A1 Macrocyclic peptides active against the hepatitis c virus |
10/12/2000 | WO2000059928A1 Chemokine-derived synthetic peptides |
10/12/2000 | WO2000059925A1 A process for the production of glutamine derivatives and glutamine containing molecules |
10/12/2000 | WO2000059881A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
10/12/2000 | WO2000059867A1 Hydroxyphenyl derivatives with hiv integrase inhibitory properties |
10/12/2000 | WO2000059527A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
10/12/2000 | WO2000005250A9 Treatment of autoimmune conditions with copolymer 1 and related copolymers and peptides |
10/12/2000 | CA2369446A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
10/12/2000 | CA2368387A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
10/12/2000 | CA2365970A1 Chemokine-derived synthetic peptides |
10/12/2000 | CA2364512A1 Compound for inhibiting the influx of polymorphonuclear leukocytes (pmns) in a tissue, its selection, pharmaceutical compositions and use |
10/11/2000 | EP1043332A1 Dipeptides comprising cyclopentan-beta-amino acids |
10/11/2000 | EP1043322A1 Vitamin e derivatives |
10/11/2000 | EP1042964A1 Sweetener composition |
10/11/2000 | EP1042963A1 Granular sweetener |
10/11/2000 | EP1042359A1 Kappa receptor opioid peptides |
10/11/2000 | EP1042288A1 Tripeptidyl peptidase inhibitors |
10/11/2000 | EP1042286A1 Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
10/11/2000 | EP0831100B1 Novel peptide derivatives |
10/11/2000 | CN1269806A Piptides containing arginine mimetic for treatment of bone metabolic disorders, their production and drugs containing these compounds |
10/11/2000 | CN1269795A Method for preparing alkyloxy furnanone derivatives, compounds obtained by said method and use of said compounds |
10/11/2000 | CN1269781A Method of purifying and recovering sweetener |
10/11/2000 | CN1269364A Somatotropin releasing peptide |
10/10/2000 | US6130315 Substrates in which the scissile amide bond has been replaced by an activated electrophilic ketone moiety; antiinflammatory agents; antiproliferative/anticarcinogenic/antiarthritic agents; treatment of autoimmune diseases |
10/10/2000 | US6130204 Peptides |
10/10/2000 | US6129942 With a conjugate base derived by deprotonation of an acidic sweetener, such as saccharin, acesulfame, cyclamic acid and glycyrrhizic acid |
10/10/2000 | CA2020346C Antibiotic ge 2270 factors a1, a2, a3 and h |
10/05/2000 | WO2000058478A1 MICROBIOLOGICAL PRODUCTION METHOD FOR α-L-ASPARTYL-L-PHENYLALANINE |
10/05/2000 | WO2000058347A1 Cosmetic or dermopharmaceutical compositions containing tripeptide n-biotinyl-gly-his-lys for the prevention, reduction or suppression of hair loss and stimulation of regrowth |
10/05/2000 | WO2000058346A1 N-sulfonyl-dipeptide derivatives, production and use thereof in therapy |
10/05/2000 | WO2000005249A3 Synthetic peptides and methods of use for autoimmune disease therapies |
10/05/2000 | DE19909373A1 Neue PNA-Monomere, daraus resultierende PNA-Oligomere und deren Verwendung New PNA monomers, resulting PNA oligomers and their use |
10/05/2000 | CA2365594A1 Microbiological production method for .alpha.-l-aspartyl-l-phenylalanine |
10/04/2000 | EP1041082A1 Process of peptidic synthesis starting from N-carboxyanhydride amino acids |
10/04/2000 | EP1040119A2 Hemiasterlin analogs |
10/04/2000 | EP1040096A1 Neuroprotective agents |
10/04/2000 | EP1039923A1 Gamma-conopeptides |
10/04/2000 | EP1039886A1 Hiv/fiv protease inhibitors having a small p3 residue |
10/04/2000 | EP1039804A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
10/04/2000 | CN1057095C Novel peptides, prepn. and use thereof |
10/03/2000 | US6127569 Crystallization of α-L-aspartyl-L-phenylalanine methyl ester |
10/03/2000 | US6127391 Compounds with growth hormone releasing properties |
10/03/2000 | US6127341 Aminomethyl-n-(1-((2-(2-thienyl)-1-(1-carbamoyl-5 -aminopentylcarbamoyl)ethyl)-n-methylcarbamoyl)-2-(2 -napthyl)ethyl)benzamide, for example; administering to stimulate growth, milk or wool production in animals |
10/03/2000 | US6127340 Espcecially thrombin, in which the p1-p2 natural amide linkage is replaced by another bond; inhibiting coagulation of blood in a container; treatment or prevention of thrombosis |
10/03/2000 | US6127339 Peptide for binding thereto a low density lipoprotein |
10/03/2000 | US6127333 Conjugates useful in the treatment of prostate cancer |
10/03/2000 | US6126939 Anti-inflammatory dipeptide and pharmaceutical composition thereof |
10/03/2000 | CA2000342C Novel peptidase inhibitors |
10/03/2000 | CA1341106C Conformationally stabilized cell adhesion peptides |